4//SEC Filing
van Dijk Marcus Antonius 4
Accession 0000899243-23-001660
CIK 0001840229other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 10:48 AM ET
Size
7.0 KB
Accession
0000899243-23-001660
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Common Stock
2023-01-09$2.32/sh+51,628$119,777→ 51,628 total - Tax Payment
Common Stock
2023-01-09$2.32/sh−24,265$56,295→ 27,363 total
Footnotes (3)
- [F1]Reflects the executive's 2022 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.
- [F2]$2.32 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 9, 2023, the stock issuance date.
- [F3]Represents payment of tax liability by withholding shares of common stock incident to the vesting of stock.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001881659
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 10:48 AM ET
- Size
- 7.0 KB